Literature DB >> 29249583

Bronchial Blocker Versus Left Double-Lumen Endotracheal Tube for One-Lung Ventilation in Right Video-Assisted Thoracoscopic Surgery.

Yao Lu1, Wei Dai1, Zhijun Zong1, Yimin Xiao1, Di Wu2, Xuesheng Liu3, Gordon Tin Chun Wong4.   

Abstract

OBJECTIVE: The aim of this study was to compare the quality of lung deflation of a left-sided double-lumen endotracheal tube (DLT) with a bronchial blocker (BB) for one-lung ventilation in video-assisted thoracic surgery (VATS).
DESIGN: A prospective, randomized, clinical study.
SETTING: A university-affiliated teaching hospital. PARTICIPANTS: Forty-five adult patients undergoing esophageal tumor surgery using VATS with right lung deflation.
INTERVENTIONS: Patients were assigned by a computer-generated randomization sequence to either the left-sided DLT or BB group. The correct positioning of the airway device was confirmed using fiberoptic bronchoscopy.
MEASUREMENTS AND MAIN RESULTS: The variables assessed included: (1) time required to correctly place the devices and to achieve lung collapse; (2) the number of times the device malpositioned; (3) the quality of lung deflation as rated by the surgeon; (4) blood pressure and heart rate at baseline (T1), immediately before (T2) and after (T3) and 1 minute (T4) after intubation; (5) the number of patients with hypoxemia (SpO2 < 90%) during the one-lung ventilation (OLV) period; and (6) postoperative hoarseness of voice, sore throat, or pulmonary infection. Of the 45 patients approached for the study, 21 patients in the DLT group and 19 patients in the BB group were analyzed. The time required to place the device in the correct position was similar between the 2 groups. The time to achieve right lung collapse in the BB group was significantly longer (mean difference: 3.232, 95% confidence interval [CI]: 1.993-4.471; p = 0.003). The quality of lung collapse, OLV duration, number of patients with device malposition, and hypoxemia in both groups were similar. There were more patients suffering hoarseness (odds ratio [OR]: 4.85, 95% CI: 1.08-21.76; p = 0.034) or sore throat (OR: 4.29, 95% CI: 1.14-16.18; p = 0.030) in the DLT group, while no patients developed postoperative lung infection in either group. Compared to T1, systolic blood pressure (sBP), diastolic BP (dBP), and heart rate (HR) at T2 in both groups were higher (p < 0.05) in the DLT group. Then, compared to T2, sBP and dBP at T3 and T4 and HR at T3 in the DLT group were higher (p < 0.05).
CONCLUSIONS: The results of this study showed that BB is an effective alternative for left one-lung ventilation in right VATS, but requires a longer time to achieve complete lung collapse. Moreover, the use of BB caused less hemodynamic perturbation and can reduce postoperative hoarseness and sore throat.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bronchial blockers; complications; double-lumen tubes; one-lung ventilation; thoracic surgery

Mesh:

Year:  2017        PMID: 29249583     DOI: 10.1053/j.jvca.2017.07.026

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  11 in total

1.  Comparison of prophylactic effect of topical Alchemilla vulgaris in glycerine versus that of dexamethasone on postoperative sore throat after tracheal intubation using a double-lumen endobronchial tube: a randomized controlled study.

Authors:  Chan Jong Chung; Seong Yeop Jeong; Joon Ho Jeong; Sung Wan Kim; Kyung Hyun Lee; Jeong Ho Kim; Sang Yoong Park; So Ron Choi
Journal:  Anesth Pain Med (Seoul)       Date:  2021-04-15

2.  Effects of bronchial blockers on one-lung ventilation in general anesthesia: A randomized controlled trail.

Authors:  Mengliang Zheng; Zhiqiang Niu; Peng Chen; Dawei Feng; Lei Wang; Yu Nie; Benqing Wang; Zhijun Zhang; Shiqiang Shan
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

3.  The disconnection technique with the use of a bronchial blocker for improving nonventilated lung collapse in video-assisted thoracoscopic surgery.

Authors:  Qian Cheng; Zhiyong He; Ping Xue; Qianyun Xu; Minmin Zhu; Wankun Chen; Changhong Miao
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

4.  Effects of bronchial blockers on gas exchange in infants with one-lung ventilation: a single-institutional experience of 22 cases.

Authors:  Li Zhang; Yu-Ping Wang; Xiao-Fen Chen; Zi-Rogn Yan; Min Zhou
Journal:  Transl Pediatr       Date:  2020-12

5.  Anesthetic Considerations in a Patient With LVAD and COVID-19 Undergoing Video-Assisted Thoracic Surgery.

Authors:  Rutuja R Sikachi; Diana Anca
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-12-17       Impact factor: 2.628

6.  3D CT airway evaluation-guided intraluminal placement of endobronchial blocker in pediatric patients: a randomized controlled study.

Authors:  Yingyi Xu; Le Li; Jianning Hou; Na Zhang; Minting Zeng; Qianqi Qiu; Yufeng Liang; Wei Wei; Yonghong Tan
Journal:  Transl Pediatr       Date:  2021-03

Review 7.  Challenge of Lung Isolation in Patients with Vocal Cord Implants.

Authors:  Islam Mohammad Shehata; Amir Elhassan; Behrooz Zaman; Omar Viswanath
Journal:  Anesth Pain Med       Date:  2022-03-22

8.  Intubation with vivasight double-lumen tube versus conventional double-lumen tube in adult patients undergoing lung resection: A retrospective analysis.

Authors:  Manuel Granell; Giulia Petrini; Pablo Kot; Mercedes Murcia; Javier Morales; Ricardo Guijarro; José A de Andrés
Journal:  Ann Card Anaesth       Date:  2022 Jul-Sep

9.  A comparison between bronchial blockers and double-lumen tubes for patients undergoing lung resection: A propensity score-matched cohort study.

Authors:  Lin Yang; Xiaojin Wei; Bin Wang; Ruping Dai; Feng Xiao; Junmei Xu
Journal:  Int J Med Sci       Date:  2022-09-25       Impact factor: 3.642

10.  A randomised comparison of the efficacy of a Coopdech bronchial blocker and a double-lumen endotracheal tube for minimally invasive esophagectomy.

Authors:  Tian-Hua Zhang; Xiao-Qing Liu; Long-Hui Cao; Jian-Hua Fu; Wen-Qian Lin
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.